Table 4.
Cancer history by baseline AD diagnostic group.
| All cancer types | NMSC | Prostate cancer | Breast cancer | |||||
|---|---|---|---|---|---|---|---|---|
| CA+ | CA− | CA+ | CA− | CA+ | CA− | CA+ | CA− | |
| CN | 129 (33%) | 262 (67%) | 74 (19%) | 317 (81%) | 29 (7%) | 362 (93%) | 19 (5%) | 372 (95%) |
| SMC | 34 (44%) | 44 (56%) | 19 (24%) | 59 (76%) | 4 (5%) | 74 (95%) | 5 (6%) | 73 (94%) |
| MCI | 257 (31%) | 570 (69%) | 123 (15%) | 704 (85%) | 73 (9%) | 754 (91%) | 25 (3%) | 802 (97%) |
| AD | 83 (26%) | 230 (74%) | 30 (10%) | 283 (90%) | 24 (8%) | 289 (92.3%) | 9 (3%) | 304 (97%) |
| Pa | 0.025 | 0.001 | 0.610 | 0.190 | ||||
Values are expressed as count (percentage within diagnostic group). NMSC, non-melanoma skin cancer.
a
P-values for Chi-square analyses of each listed cancer type (or all) by diagnostic group.